We are live on
!
Find out more
FBB
Fulton Breakefield Broenniman Portfolio holdings
AUM
$1.53B
1-Year Est. Return
18.11%
This Fund
S&P 500
This Quarter
Est. Return
+3.66%
1 Year Est. Return
+18.11%
3 Year Est. Return
+57.23%
5 Year Est. Return
+68.56%
10 Year Est. Return
+240.26%
AUM
$1.58B
AUM Growth
+$36.1M
(+2.3%)
Cap. Flow
-$6.36M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
46.3%
Holding
217
New
13
Increased
57
Reduced
106
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$17.4M |
| 2 |
SPDR Gold MiniShares Trust
GLDM
|
+$10.1M |
| 3 |
Spotify
SPOT
|
+$7.39M |
| 4 |
Hilton Worldwide
HLT
|
+$6.67M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$6.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$8.61M |
| 2 |
Automatic Data Processing
ADP
|
+$7.65M |
| 3 |
Church & Dwight Co
CHD
|
+$7.18M |
| 4 |
IBDQ
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
|
+$5.83M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$5.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Financials | 11.07% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 6.81% |
| 5 | Healthcare | 6.64% |
Similar funds
SG
FI
HR
MCP
CCM
CCP
ICM
GHC
Fulton Breakefield Broenniman's Q4 2025 Portfolio in Review
As of Q4 2025, Fulton Breakefield Broenniman held 217 positions worth $1.58B, up 2.3% from $1.55B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Fulton Breakefield Broenniman's Q4 2025 filing shows 13 new, 57 increased, 106 reduced and 14 closed positions. Its largest new stake was Spotify: 11,816 shares worth $6.86M. The largest sale was Eli Lilly, an estimated $8.61M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Fulton Breakefield Broenniman's largest Q4 2025 buy was Spotify: 11,816 shares worth $6.86M.
- Fulton Breakefield Broenniman added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $17.4M increase.
- Fulton Breakefield Broenniman's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $8.61M.
- Fulton Breakefield Broenniman fully exited iShares iBonds Dec 2025 Term Corporate ETF in Q4 2025, selling an estimated $5.83M.
- Fulton Breakefield Broenniman's ten largest holdings make up 46% of its $1.58B portfolio in Q4 2025.
- Fulton Breakefield Broenniman opened 13 new positions and closed 14 in Q4 2025.
- Fulton Breakefield Broenniman's portfolio value rose 2.3% quarter-over-quarter to $1.58B.
Based on Fulton Breakefield Broenniman's 13F filing for Q4 2025, filed 21 Jan 2026.